Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis

Journal:

European Heart Journal

Published:

2025-06-02

DOI:

10.1093/eurheartj/ehaf362

Affiliations:

28

Authors:

32

Go to article

Institutions	Authors	Share
Medical University of Vienna (MUW), Austria	5.500000	0.17
Bern University Hospital, Switzerland	2.000000	0.06
University Hospital of Münster (UKM), WWU, Germany	2.000000	0.06
ERN GUARD-HEART, Italy, Italy	1.833333	0.06
Barts Heart Centre, United Kingdom (UK)	1.666667	0.05
St Bartholomew's Hospital, United Kingdom (UK)	1.666667	0.05
University Hospital Frankfurt, GU, Germany	1.500000	0.05
University of Trieste (UNITS), Italy	1.166667	0.04
Azienda sanitaria universitaria Giuliano Isontina (ASU GI), Italy	1.166667	0.04
UCL, United Kingdom (UK)	1.166667	0.04
New York-Presbyterian Hospital, United States of America (USA)	1.000000	0.03
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)	1.000000	0.03
Medical University of South Carolina (MUSC), United States of America (USA)	1.000000	0.03
Hospital de Santa Cruz, Portugal	1.000000	0.03
Rabin Medical Center (RMC), TAU, Israel	1.000000	0.03
John Radcliffe Hospital, United Kingdom (UK)	1.000000	0.03
Vilnius University (VU), Lithuania	1.000000	0.03
Minneapolis Heart Institute Foundation (MHIF), United States of America (USA)	1.000000	0.03
University of Bologna (UNIBO), Italy	0.666667	0.02
Sant'Orsola Malpighi Hospital, Italy	0.666667	0.02
West German Heart and Vascular Center Essen (WHGZ), Germany	0.500000	0.02
University Medical Center Utrecht (UMC Utrecht), Netherlands	0.500000	0.02
University Medical Center Göttingen (UMG), Germany	0.500000	0.02
Forum Medizin, Germany	0.500000	0.02
Royal Free Hospital, United Kingdom (UK)	0.500000	0.02
University Hospital of St. Poelten, KL, Austria	0.500000	0.02

Interested in Pharmacology and Pharmaceutical Sciences?